Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNNY trial: PDS vs NAC/IDS in stage IIIC/IV ovarian cancer
jRCTs051190090Phase 3Active, not recruiting
- Sponsor
- Japanese Gynecologic Oncology Group
- Start
- Jun 2020
01
Overview
Phase 3, randomised, open-label trial in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) (2 arms), sponsored by Japanese Gynecologic Oncology Group. Primary endpoint: overall survival. Started Jun 2020; status: active, not recruiting.
02
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on jRCTs051190090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190090.